Filter
361
Text search:
guidelines
for
pharmacovigilance
Featured
49
119
Language
Document type
198
62
41
23
18
6
6
4
1
1
1
Countries / Regions
22
14
13
13
13
12
11
11
10
10
9
9
7
7
7
7
7
5
5
5
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
184
51
11
8
7
6
2
Toolboxes
48
44
31
21
20
13
4
3
3
2
2
1
1
1
1
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid,
...
Accessed November 2017
HIV Treatment
Policy Brief
July 2017
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported
...
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
2014-2020, Draft March 2014
Master of Science in Pharmaceutical Management Dissertation
Celebrating ten years of success 2004-2014
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
8–18 December 2015
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr
...
